Avraham Pharmaceuticals Raises $5.7M

By Anouk Lorie February 22, 2013 Comments

Avraham Pharmaceuticals Raises $5.7MIsraeli company Avraham Pharmaceuticals Ltd., which is developing ladostigil, a novel molecule designed for the treatment of mild cognitive impairment (MCI) and early stages of Alzheimer’s disease, has announced that it has raised $5.7 million. The investment was made by Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, Pontifax, Clal Biotechnology Industries and the Technion Research and Development Foundation Ltd.

Facebook Comments
Load more